Braidwell
Overview
Braidwell is a life science-focused investment firm that partners with companies developing paradigm-shifting therapeutic technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lila Sciences | Oct 2025 | Series A Extension | Co-investor |
| Caris Life Sciences | Apr 2025 | Growth Equity | Lead |
| Day One Biopharmaceuticals | Aug 2024 | Private Placement | Co-investor |
| Alamar Biosciences | Jan 2026 | Convertible Debt | Co-investor |
| Jade Biosciences, Inc. | Apr 2025 | M&A | Co-investor |
For institutional investors. Book with your work email.
Key People
Brian Kreiter
Co-Founder And Chief Executive Officer
Adrian Demko
Partner, Head of Trading
Colin Bettison
Partner
Jonathan Lee
Partner
Kaila Krum
Partner
Laura Sterner
Partner
Matt Wilson
Partner
Michael Metschl
Partner, Head Of Therapeutics
Ming Zhu
Partner
Narendra Nayak
Partner
Nick Myerberg
Partner
Sommer Chatwin
Partner
Hannah Waxman
Director, Business Development Investor Relations
Hannah Waxman Stoczko
Director, Business Development & Investor Relations
Anthony Melendez
Biotech Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Braidwell based?
Braidwell is headquartered in Stamford, Connecticut, United States.
When was Braidwell founded?
Braidwell was founded in 2021.
How many portfolio companies does Braidwell have?
Braidwell has 15 portfolio companies in Caplight's dataset.
What are some companies in Braidwell's portfolio?
Portfolio companies visible on Caplight include Lila Sciences, Caris Life Sciences, Day One Biopharmaceuticals, Alamar Biosciences, Jade Biosciences, Inc..
What was Braidwell's most recent investment shown here?
Braidwell's most recent investment in this portfolio sample was in Alamar Biosciences in 2026.
What sectors does Braidwell focus on?
Braidwell focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Braidwell focus on?
Braidwell typically invests at the MultiStage stage.
What is Braidwell's AUM?
Braidwell's assets under management are estimated between $5.2B and $7.5B.